CAPTRUST FINANCIAL ADVISORS

Position in RGNX — REGENXBIO Inc.

CIK 1512024 RALEIGH, NC

Position in RGNX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$158,555

+$38,990 QoQ

Shares Held

13,235

-7.2% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#106

of 164 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 29% Shared 0% None 71%

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. RGNX ranks #76 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	36,464	$22,736,762
2	RPRX	Royalty Pharma plc	337,298	$18,912,298
3	VRTX	Vertex Pharmaceuticals Inc / Ma	35,471	$17,619,509
4	EXEL	Exelixis, Inc.	303,042	$16,488,515
5	LGND	Ligand Pharmaceuticals Inc	34,607	$10,938,926
6	HALO	Halozyme Therapeutics, Inc.	125,946	$9,857,793
7	CELC	Celcuity Inc.	71,445	$7,474,575
8	INCY	Incyte Corp	50,301	$5,702,121

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$158,555	13,235	-7.2%	Shares	Sole	2026-08-13
2026-03-31	$119,565	14,268	-6.3%	Shares	Sole	2026-05-15
2025-12-31	$219,283	15,228	+13.2%	Shares	Sole	2026-02-17
2025-09-30	$129,763	13,447	+29.1%	Shares	Sole	2025-11-19
2025-06-30	$85,498	10,414	+1615.7%	Shares	Sole	2025-08-15
2022-06-30	$14,992	607	-36.8%	Shares	Sole	2022-08-23
2022-03-31	$31,862	960	+742.1%	Shares	Sole	2022-05-16
2021-12-31	$3,727	114	+14.0%	Shares	Sole	2022-02-14
2021-09-30	$4,192	100	+26.6%	Shares	Sole	2021-11-16
2021-06-30	$3,069	79	-14.1%	Shares	Sole	2021-08-16
2021-03-31	$3,138	92	+67.3%	Shares	Sole	2021-05-17
2020-12-31	$2,494	55	+83.3%	Shares	Sole	2021-02-16
2020-09-30	$825	30	—	Shares	Sole	2020-11-17
No filing history on record for this holder in this stock.